The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumLong Ideas - Idenix Pharmaceuticals (NASDAQ:IDIX) announced Tuesday morning that the company will be restructuring its partnership strategy with Novartis (NYSE:NVS). The announcement nullifies licensing of Tyzeka (IDIX’s … Continue Reading
Read now- Array BioPHarma (NASDAQ:ARRY) announced that its novel treatment for pain, ARRY-797, met its primary endpoint in a Phase 2 clinical trial, however, safety issues are … Continue Reading
Read now- At least three analysts have downgraded Auxilium Pharmaceuticals (NASDAQ:AUXL) this morning after the company reported strong second quarter earnings yesterday, with the stock approaching its … Continue Reading
Read nowLong Ideas - Shares of Horizon Pharmaceuticals (NASDAQ:HZNP) have traded down 25% since the FDA’s approval of Rayos, the company’s delayed-release arthritis drug, last Thursday. As with most … Continue Reading
Read nowLong Ideas - After immense pre-market trading, Dendreon (NASDAQ:DNDN) is down 22% to $4.85 on earnings and news that it will cut 600 jobs and close a New … Continue Reading
Read nowLong Ideas - Amarin Corp. (NASDAQ:AMRN) is trading sharply lower this morning on reports that members of management and the Board sold company stock and exercised options after … Continue Reading
Read nowLong Ideas - This morning, the little-known Omeros Corporation (NASDAQ:OMER) announced that it may have discovered the proteins that activate the alternative pathway of the complement system, an … Continue Reading
Read now
